A detailed history of Federated Hermes, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 896,238 shares of MRK stock, worth $85.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
896,238
Previous 1,059,521 15.41%
Holding current value
$85.8 Million
Previous $131 Million 22.41%
% of portfolio
0.23%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $18.1 Million - $21.1 Million
-163,283 Reduced 15.41%
896,238 $102 Million
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $4.52 Million - $4.85 Million
36,474 Added 3.57%
1,059,521 $131 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $10.7 Million - $12.5 Million
94,729 Added 10.2%
1,023,047 $135 Million
Q4 2023

Jan 31, 2024

SELL
$100.18 - $109.02 $1.07 Million - $1.16 Million
-10,639 Reduced 1.13%
928,318 $101 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $16.2 Million - $18 Million
157,300 Added 20.12%
938,957 $96.7 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $12.7 Million - $13.8 Million
116,786 Added 17.57%
781,657 $90.2 Million
Q1 2023

May 08, 2023

SELL
$102.94 - $114.86 $313 Million - $349 Million
-3,037,634 Reduced 82.04%
664,871 $70.7 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $63.2 Million - $81.1 Million
-723,032 Reduced 16.34%
3,702,505 $411 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $11.2 Million - $12.6 Million
-132,512 Reduced 2.91%
4,425,537 $381 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $79.5 Million - $90.1 Million
-951,752 Reduced 17.27%
4,558,049 $416 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $46.6 Million - $52.2 Million
-633,910 Reduced 10.32%
5,509,801 $452 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $112 Million - $140 Million
-1,544,339 Reduced 20.09%
6,143,711 $471 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $45.4 Million - $50 Million
633,775 Added 8.98%
7,688,050 $623 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $107 Million - $118 Million
1,521,965 Added 27.51%
7,054,275 $549 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $60.8 Million - $71.6 Million
882,714 Added 18.98%
5,532,310 $426 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $1.17 Million - $1.3 Million
16,357 Added 0.35%
4,649,596 $380 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $37.5 Million - $42.5 Million
512,764 Added 12.44%
4,633,239 $384 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $56.8 Million - $64.6 Million
806,664 Added 24.34%
4,120,475 $319 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $164 Million - $227 Million
2,584,507 Added 354.38%
3,313,811 $255 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $2.45 Million - $2.76 Million
-31,548 Reduced 4.15%
729,304 $66.3 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $5.54 Million - $6.04 Million
-72,779 Reduced 8.73%
760,852 $64 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $54.9 Million - $64.1 Million
-785,595 Reduced 48.52%
833,631 $69.9 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $3.59 Million - $4.09 Million
-51,570 Reduced 3.09%
1,619,226 $135 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $9.51 Million - $11 Million
145,764 Added 9.56%
1,670,796 $122 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $19.4 Million - $22.8 Million
335,894 Added 28.25%
1,525,032 $108 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $277 Million - $325 Million
-5,446,850 Reduced 82.08%
1,189,138 $72.2 Million
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $118 Million - $137 Million
-2,319,851 Reduced 25.9%
6,635,988 $361 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $16.8 Million - $20 Million
-324,959 Reduced 3.5%
8,955,839 $0
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $545 Million - $586 Million
9,280,798
9,280,798 $594 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.